American Heart Association Ventures is the Dallas-based venture capital arm of the American Heart Association, backing U.S. seed and early-stage companies advancing cardiovascular and brain health. It invests across health technology, medical devices, women’s health, biotechnology, AI-enabled health and impact-oriented solutions addressing social drivers of health. The platform includes initiatives such as the Go Red for Women Venture Fund, Social Impact Funds, Studio Red and Cardeation Capital, and is relevant for founders translating evidence-based science into commercial health products and services.